Ann Baker and John Cole are speaking on this topic. This webinar will examine the motivations for collaboration between biopharma and academia – two different worlds. Crucially, we will also reflect on why the outcomes of such collaborations often disappoint and consider some of the interventions that both parties can make to ensure a successful outcome. We will look at how to bridge the gap between academia and biopharma.
For more information on this event, click here.
Inequities in patient support, well-being, and treatment access for triple negative breast cancer patients
In this report, Charles River Associates (CRA) and Cancer Support Community (CSC) examine the extent to which policies associated with long-term support,...